EverPoint Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

EverPoint Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-500,000	Closed	-$7.6M	–	636
2015 Q1	$7.6M	Hold	500,000	–	–	0.14%	203
2014 Q4	$6.02M	Buy	500,000 +400,000	+400%	+$4.57M	0.14%	224
2014 Q3	$1.13M	Sell	100,000 -700,000	-88%	-$7.98M	0.03%	384
2014 Q2	$9.66M	Buy	+800,000	New	+$9.45M	0.2%	151

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's MNTA Position: Q2 2015 in Review

EverPoint Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2015, closing a stake of 500,000 shares — an estimated $7.6M sold.

EverPoint Asset Management first reported a position in MNTA in Q2 2014 and held it in 4 quarters. The position peaked at $9.66M in Q2 2014. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

EverPoint Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
EverPoint Asset Management sold 500,000 Momenta Pharmaceuticals, Inc. shares in Q2 2015, an estimated $7.6M.
EverPoint Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
EverPoint Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $9.66M in Q2 2014.
162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on EverPoint Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.